vs
Amarin Corp plc（AMRN）与FGI Industries Ltd.（FGI）财务数据对比。点击上方公司名可切换其他公司
Amarin Corp plc的季度营收约是FGI Industries Ltd.的1.5倍（$45.1M vs $30.5M），FGI Industries Ltd.净利率更高（-8.6% vs -23.3%，领先14.7%），Amarin Corp plc同比增速更快（7.0% vs -14.4%），过去两年FGI Industries Ltd.的营收复合增速更高（-0.5% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
FGI Industries Ltd是一家全球厨卫产品、家居收纳解决方案及家装用品的设计、制造与分销商，服务覆盖北美、欧洲及亚太地区的大型连锁零售商、家居专营店和电商平台。
AMRN vs FGI — 直观对比
营收规模更大
AMRN
是对方的1.5倍
$30.5M
营收增速更快
AMRN
高出21.4%
-14.4%
净利率更高
FGI
高出14.7%
-23.3%
两年增速更快
FGI
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $30.5M |
| 净利润 | $-10.5M | $-2.6M |
| 毛利率 | — | 26.7% |
| 营业利润率 | 35.5% | -2.2% |
| 净利率 | -23.3% | -8.6% |
| 营收同比 | 7.0% | -14.4% |
| 净利润同比 | 33.0% | -553.1% |
| 每股收益（稀释后） | — | $-1.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNFGI
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $30.5M | ||
| Q3 25 | $49.7M | $35.8M | ||
| Q2 25 | $72.7M | $31.0M | ||
| Q1 25 | $42.0M | $33.2M | ||
| Q4 24 | $62.3M | $35.6M | ||
| Q3 24 | $42.3M | $36.1M | ||
| Q2 24 | $67.5M | $29.4M |
净利润AMRNFGI
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $-2.6M | ||
| Q3 25 | $-7.7M | $-1.7M | ||
| Q2 25 | $-14.1M | $-1.2M | ||
| Q1 25 | $-15.7M | $-629.1K | ||
| Q4 24 | $-48.6M | $-402.3K | ||
| Q3 24 | $-25.1M | $-550.1K | ||
| Q2 24 | $1.5M | $163.6K |
毛利率AMRNFGI
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | 26.7% | ||
| Q3 25 | 44.7% | 26.5% | ||
| Q2 25 | 69.2% | 28.1% | ||
| Q1 25 | 59.8% | 26.8% | ||
| Q4 24 | -15.4% | 24.6% | ||
| Q3 24 | 38.5% | 25.8% | ||
| Q2 24 | 63.4% | 30.5% |
营业利润率AMRNFGI
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | -2.2% | ||
| Q3 25 | -22.4% | 1.0% | ||
| Q2 25 | -22.0% | -2.7% | ||
| Q1 25 | -39.9% | -3.9% | ||
| Q4 24 | -84.3% | -3.5% | ||
| Q3 24 | -59.5% | -0.2% | ||
| Q2 24 | -0.8% | -1.5% |
净利率AMRNFGI
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | -8.6% | ||
| Q3 25 | -15.6% | -4.6% | ||
| Q2 25 | -19.4% | -4.0% | ||
| Q1 25 | -37.4% | -1.9% | ||
| Q4 24 | -78.0% | -1.1% | ||
| Q3 24 | -59.4% | -1.5% | ||
| Q2 24 | 2.3% | 0.6% |
每股收益（稀释后）AMRNFGI
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $-1.63 | ||
| Q3 25 | $-0.02 | $-0.86 | ||
| Q2 25 | $-0.03 | $-0.64 | ||
| Q1 25 | $-0.04 | $-0.07 | ||
| Q4 24 | $-0.12 | $-0.38 | ||
| Q3 24 | $-0.06 | $-0.29 | ||
| Q2 24 | $0.00 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $1.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $17.3M |
| 总资产 | $645.8M | $69.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMRNFGI
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $1.9M | ||
| Q3 25 | $286.6M | $1.9M | ||
| Q2 25 | $298.7M | $2.5M | ||
| Q1 25 | $281.8M | $1.2M | ||
| Q4 24 | $294.2M | $4.6M | ||
| Q3 24 | $305.7M | $3.0M | ||
| Q2 24 | $306.7M | $1.3M |
股东权益AMRNFGI
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $17.3M | ||
| Q3 25 | $458.9M | $19.7M | ||
| Q2 25 | $464.9M | $21.3M | ||
| Q1 25 | $473.7M | $21.8M | ||
| Q4 24 | $486.2M | $22.3M | ||
| Q3 24 | $531.4M | $23.5M | ||
| Q2 24 | $551.9M | $23.8M |
总资产AMRNFGI
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $69.5M | ||
| Q3 25 | $659.8M | $73.0M | ||
| Q2 25 | $670.1M | $71.7M | ||
| Q1 25 | $655.7M | $68.5M | ||
| Q4 24 | $685.3M | $75.5M | ||
| Q3 24 | $750.6M | $74.7M | ||
| Q2 24 | $799.9M | $69.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $2.3M |
| 自由现金流经营现金流 - 资本支出 | — | $2.3M |
| 自由现金流率自由现金流/营收 | — | 7.5% |
| 资本支出强度资本支出/营收 | — | 0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-212.5K |
8季度趋势，按日历期对齐
经营现金流AMRNFGI
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $2.3M | ||
| Q3 25 | $-12.7M | $-1.9M | ||
| Q2 25 | $16.6M | $7.6M | ||
| Q1 25 | $-12.5M | $-7.4M | ||
| Q4 24 | $-13.3M | $617.4K | ||
| Q3 24 | $-2.4M | $-915.0K | ||
| Q2 24 | $-2.7M | $862.1K |
自由现金流AMRNFGI
| Q1 26 | — | — | ||
| Q4 25 | — | $2.3M | ||
| Q3 25 | — | $-2.1M | ||
| Q2 25 | — | $7.4M | ||
| Q1 25 | — | $-7.7M | ||
| Q4 24 | — | $-214.1K | ||
| Q3 24 | — | $-1.1M | ||
| Q2 24 | — | $281.5K |
自由现金流率AMRNFGI
| Q1 26 | — | — | ||
| Q4 25 | — | 7.5% | ||
| Q3 25 | — | -5.9% | ||
| Q2 25 | — | 23.8% | ||
| Q1 25 | — | -23.3% | ||
| Q4 24 | — | -0.6% | ||
| Q3 24 | — | -3.0% | ||
| Q2 24 | — | 1.0% |
资本支出强度AMRNFGI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 2.0% |
现金转化率AMRNFGI
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.81× | 5.27× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
FGI
| Sanitaryware | $19.1M | 63% |
| Shower System | $5.8M | 19% |
| Kitchen And Bath Other | $3.3M | 11% |
| Bath Furniture Products | $2.3M | 7% |
